Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Chris Lau
»
Comments
»
GCI
Chris Lau
63
Followers
23
Following
You are currently following Chris Lau
Stop Following
You are no longer following Chris Lau
Profile
Articles (18)
Instablog (
11
)
StockTalk (
3
)
Comments (55)
10 Top Dividend Stocks of the S&P 500
[
View article
]
The table needs to look at the Cash flow per share and to compare that to the dividend payout.
Fundamentally, i'd avoid auto, am not completely sure where pharmas fit (too much competition, and politics are pushing for lower health care costs).
Jul 09 15:46 pm
|
Rating:
0
0
|
Link to Comment
More on GCI by Chris Lau
Articles »
Instablogs »
StockTalks »
Comments by Ticker
AAPL
,
ACAS
,
ACH
,
ADP
,
AMR
,
AMZN
,
ATVI
,
BAC
,
BBT
,
BIDU
,
BIV
,
BK
,
BMY
,
BND
,
BNI
,
BRK.A
,
BRK.B
,
BSV
,
BVF
,
C
,
CAL
,
CAT
,
CEO
,
CHH
,
CHL
,
CMA
,
CNY
,
CREE
,
CSIQ
,
CTRP
,
CYB
,
DAL
,
DBC
,
DBO
,
DDR
,
DELL
,
DIA
,
DOG
,
EDU
,
EFA
,
ENER
,
ERO
,
ERTS
,
ESLR
,
F
,
FAZ
,
FDX
,
FNM
,
FRE
,
FRI
,
FSLR
,
FTR
,
FTY
,
FXE
,
FXI
,
FXP
,
GBB
,
GCI
,
GD
,
GE
,
GGWPQ.PK
,
GLD
,
GME
,
GMGMQ.PK
,
GOOG
,
GRMN
,
GS
,
GSG
,
GSH
,
GSK
,
GXC
,
HAO
,
HBAN
,
HMIN
,
ICF
,
IEV
,
IVV
,
IYF
,
IYG
,
IYR
,
JASO
,
JNJ
,
JPM
,
JST
,
KBE
,
KBW
,
KEY
,
LDK
,
LEH
,
LFC
,
LLY
,
MBI
,
MER
,
MI
,
MR
,
MRK
,
MS
,
MSFT
,
NOK
,
NTDOY.PK
,
NTES
,
NVS
,
OIL
,
PALM
,
PFE
,
PGJ
,
PLD
,
POT
,
PSQ
,
PTR
,
PWRD
,
Q
,
QQQQ
,
RAI
,
RF
,
RHT
,
RTL
,
RWR
,
SH
,
SHV
,
SINA
,
SKF
,
SLV
,
SLW
,
SNDA
,
SNE
,
SNP
,
SOHU
,
SOL
,
SOLF
,
SPG
,
SPWRA
,
SPY
,
SRS
,
STI
,
STP
,
T
,
TAO
,
TOL
,
TRN
,
TSL
,
TTWO
,
UAUA
,
UBS
,
UDN
,
USB
,
USO
,
UUP
,
VEA
,
VECO
,
VMW
,
VNQ
,
WB
,
WFC
,
WIN
,
WMT
,
WYE
,
XHB
,
XL
,
XLF
,
XOM
,
YGE
,
YHOO
,
YZC
Chris Lau's
Comments Stats
55 comments
Rating:
11
(25
-
14
)
10 Top Dividend Stocks of the S&P 500 [View article]
Fundamentally, i'd avoid auto, am not completely sure where pharmas fit (too much competition, and politics are pushing for lower health care costs).